Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...
This strategic move brings stability to Embecta, addressing challenges faced since its spin-off from Becton Dickinson & Co.
Physicians identified key improvements for adrenaline auto-injectors, including longer shelf life and easier use, improving anaphylaxis care. Learn more.
Alerje founder Javier Evelyn’s mobile auto-injector platform was recently acquired by Sempresto.
The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...
It's that time of year again as the 2026 Cleveland Auto Show races into the I-X Center with the annual 10-day event running from Feb. 20 through March 1. Want to go? We've compiled a complete guide ...
Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...
As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys breaking ...
Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...
A concerning program by Eli Lilly ties increased copay assistance for one of its top-selling brand-name drugs, tirzepatide (Zepbound), to having a prescription for another, ixekizumab (Taltz). Called ...
Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Holdings Limited.
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. An auto equity loan could help pay for necessary expenses, but research your ...